206 related articles for article (PubMed ID: 33836581)
1. Enhanced cytarabine-induced killing in OGG1-deficient acute myeloid leukemia cells.
Owen N; Minko IG; Moellmer SA; Cammann SK; Lloyd RS; McCullough AK
Proc Natl Acad Sci U S A; 2021 Mar; 118(11):. PubMed ID: 33836581
[TBL] [Abstract][Full Text] [Related]
2. Expression of human oxoguanine glycosylase 1 or formamidopyrimidine glycosylase in human embryonic kidney 293 cells exacerbates methylmercury toxicity in vitro.
Ondovcik SL; Preston TJ; McCallum GP; Wells PG
Toxicol Appl Pharmacol; 2013 Aug; 271(1):41-8. PubMed ID: 23607987
[TBL] [Abstract][Full Text] [Related]
3. Oxidatively-induced DNA base damage and base excision repair abnormalities in siblings of individuals with bipolar disorder DNA damage and repair in bipolar disorder.
Arat Çelik HE; Yılmaz S; Akşahin İC; Kök Kendirlioğlu B; Çörekli E; Dal Bekar NE; Çelik ÖF; Yorguner N; Targıtay Öztürk B; İşlekel H; Özerdem A; Akan P; Ceylan D; Tuna G
Transl Psychiatry; 2024 May; 14(1):207. PubMed ID: 38789433
[TBL] [Abstract][Full Text] [Related]
4. Association between OGG1 S326C CC genotype and elevated relapse risk in acute myeloid leukemia.
Gotoh N; Saitoh T; Takahashi N; Kasamatsu T; Minato Y; Lobna A; Oda T; Hoshino T; Sakura T; Shimizu H; Takizawa M; Handa H; Yokohama A; Tsukamoto N; Murakami H
Int J Hematol; 2018 Sep; 108(3):246-253. PubMed ID: 29737460
[TBL] [Abstract][Full Text] [Related]
5. Repair of 8-oxo-7,8-dihydroguanine in prokaryotic and eukaryotic cells: Properties and biological roles of the Fpg and OGG1 DNA N-glycosylases.
Boiteux S; Coste F; Castaing B
Free Radic Biol Med; 2017 Jun; 107():179-201. PubMed ID: 27903453
[TBL] [Abstract][Full Text] [Related]
6. Alterations in levels of 8-Oxo-2'-deoxyguanosine and 8-Oxoguanine DNA glycosylase 1 during a current episode and after remission in unipolar and bipolar depression.
Ceylan D; Yılmaz S; Tuna G; Kant M; Er A; Ildız A; Verim B; Akış M; Akan P; İşlekel H; Veldic M; Frye M; Özerdem A
Psychoneuroendocrinology; 2020 Apr; 114():104600. PubMed ID: 32062372
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of PARP1 transcription by CDK4/6 inhibitors sensitizes human lung cancer cells to anticancer drug-induced death by impairing OGG1-dependent base excision repair.
Tempka D; Tokarz P; Chmielewska K; Kluska M; Pietrzak J; Rygielska Ż; Virág L; Robaszkiewicz A
Redox Biol; 2018 May; 15():316-326. PubMed ID: 29306194
[TBL] [Abstract][Full Text] [Related]
8. Small Molecule Inhibitors of 8-Oxoguanine DNA Glycosylase-1 (OGG1).
Donley N; Jaruga P; Coskun E; Dizdaroglu M; McCullough AK; Lloyd RS
ACS Chem Biol; 2015 Oct; 10(10):2334-43. PubMed ID: 26218629
[TBL] [Abstract][Full Text] [Related]
9. Use of a molecular beacon to track the activity of base excision repair protein OGG1 in live cells.
Mirbahai L; Kershaw RM; Green RM; Hayden RE; Meldrum RA; Hodges NJ
DNA Repair (Amst); 2010 Feb; 9(2):144-52. PubMed ID: 20042377
[TBL] [Abstract][Full Text] [Related]
10. OGG1-initiated base excision repair exacerbates oxidative stress-induced parthanatos.
Wang R; Li C; Qiao P; Xue Y; Zheng X; Chen H; Zeng X; Liu W; Boldogh I; Ba X
Cell Death Dis; 2018 May; 9(6):628. PubMed ID: 29795387
[TBL] [Abstract][Full Text] [Related]
11. Radotinib enhances cytarabine (Ara-C)-induced acute myeloid leukemia cell death.
Heo SK; Noh EK; Yu HM; Kim DK; Seo HJ; Lee YJ; Cheon J; Koh SJ; Min YJ; Choi Y; Jo JC
BMC Cancer; 2020 Dec; 20(1):1193. PubMed ID: 33276759
[TBL] [Abstract][Full Text] [Related]
12. Hematopoietic growth factor stimulation and cytarabine cytotoxicity in vitro: effects in untreated and relapsed or primary refractory acute myeloid leukemia cells.
te Boekhorst PA; Löwenberg B; Sonneveld P
Leukemia; 1994 Sep; 8(9):1480-6. PubMed ID: 7522289
[TBL] [Abstract][Full Text] [Related]
13. The recombination protein RAD52 cooperates with the excision repair protein OGG1 for the repair of oxidative lesions in mammalian cells.
de Souza-Pinto NC; Maynard S; Hashiguchi K; Hu J; Muftuoglu M; Bohr VA
Mol Cell Biol; 2009 Aug; 29(16):4441-54. PubMed ID: 19506022
[TBL] [Abstract][Full Text] [Related]
14. HOTAIRM1 knockdown enhances cytarabine-induced cytotoxicity by suppression of glycolysis through the Wnt/β-catenin/PFKP pathway in acute myeloid leukemia cells.
Chen L; Hu N; Wang C; Zhao H
Arch Biochem Biophys; 2020 Feb; 680():108244. PubMed ID: 31904363
[TBL] [Abstract][Full Text] [Related]
15. OGG1 is a novel prognostic indicator in acute myeloid leukaemia.
Liddiard K; Hills R; Burnett AK; Darley RL; Tonks A
Oncogene; 2010 Apr; 29(13):2005-12. PubMed ID: 20023702
[TBL] [Abstract][Full Text] [Related]
16. A bioluminescent microbial biosensor for in vitro pretreatment assessment of cytarabine efficacy in leukemia.
Alloush HM; Anderson E; Martin AD; Ruddock MW; Angell JE; Hill PJ; Mehta P; Smith MA; Smith JG; Salisbury VC
Clin Chem; 2010 Dec; 56(12):1862-70. PubMed ID: 20921267
[TBL] [Abstract][Full Text] [Related]
17. Activity of OGG1 variants in the repair of pro-oxidant-induced 8-oxo-2'-deoxyguanosine.
Smart DJ; Chipman JK; Hodges NJ
DNA Repair (Amst); 2006 Nov; 5(11):1337-45. PubMed ID: 16861056
[TBL] [Abstract][Full Text] [Related]
18. Targeting SAMHD1 with the Vpx protein to improve cytarabine therapy for hematological malignancies.
Herold N; Rudd SG; Ljungblad L; Sanjiv K; Myrberg IH; Paulin CB; Heshmati Y; Hagenkort A; Kutzner J; Page BD; Calderón-Montaño JM; Loseva O; Jemth AS; Bulli L; Axelsson H; Tesi B; Valerie NC; Höglund A; Bladh J; Wiita E; Sundin M; Uhlin M; Rassidakis G; Heyman M; Tamm KP; Warpman-Berglund U; Walfridsson J; Lehmann S; Grandér D; Lundbäck T; Kogner P; Henter JI; Helleday T; Schaller T
Nat Med; 2017 Feb; 23(2):256-263. PubMed ID: 28067901
[TBL] [Abstract][Full Text] [Related]
19. Cell cycle perturbations in acute myeloid leukemia samples following in vitro exposures to therapeutic agents.
Banker DE; Groudine M; Willman CL; Norwood T; Appelbaum FR
Leuk Res; 1998 Mar; 22(3):221-39. PubMed ID: 9619914
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of Mnk enhances apoptotic activity of cytarabine in acute myeloid leukemia cells.
Li P; Diab S; Yu M; Adams J; Islam S; Basnet SK; Albrecht H; Milne R; Wang S
Oncotarget; 2016 Aug; 7(35):56811-56825. PubMed ID: 27462781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
